Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Defining the role and therapeutic potential for regulatory T cells in controlling inflammation in type 2 diabetes
FY 2010-11
Summary
Approximately 2 million Canadians suffer from type 2 diabetes (T2D). With the growing number of diabetes patients in Canada, a better treatment is needed. T2D patients suffer from insulin resistance where the body does not respond to insulin. Aside from being a metabolic disorder, diabetes is also considered as an inflammatory disorder. T2D has been associated with increased inflammation. The onset of T2D is characterized by high levels of insulin from over-production of insulin in the body. Regulatory T cells (Tregs) are a class of white blood cells that suppress the body's unwanted inflammatory responses. Since Tregs are able to reduce inflammation, it may be a promising therapy for T2D. Here, we will deepen our understanding of Tregs in the context of T2D and explore the potential use of Tregs as an innovative therapy for T2D. I hypothesize that insulin can possibly interfere with the functions of Tregs. I will investigate whether the ability of Tregs to suppress inflammation becomes defective due to high insulin exposure. I will next study the role of Tregs in T2D, and determine whether the increased inflammation in T2D is due to high insulin exposure interfering with the normal function of Tregs. I will also explore the potential use of Tregs as a therapy to treat T2D in mouse models. Specifically, I will investigate whether therapy with Tregs can reduce inflammation and reduce insulin resistance in these models. Overall, the data obtained here will potentially lead to improvements in existing diabetes treatments, and the development of an innovative Treg based therapy to treat diabetes.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
226948
Name
Han Jonathan M
Region
British Columbia
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Defining the role and therapeutic potential for regulatory T cells in controlling inflammation in type 2 diabetes
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adipose; Flow Cytometry; Immunotherapy; Inflammation; Insulin; Mice; Regulatory T Cells; Signal Transduction; T Cell; Type 2 Diabetes
Abstract
Approximately 2 million Canadians suffer from type 2 diabetes (T2D). With the growing number of diabetes patients in Canada, a better treatment is needed. T2D patients suffer from insulin resistance where the body does not respond to insulin. Aside from being a metabolic disorder, diabetes is also considered as an inflammatory disorder. T2D has been associated with increased inflammation. The onset of T2D is characterized by high levels of insulin from over-production of insulin in the body. Regulatory T cells (Tregs) are a class of white blood cells that suppress the body's unwanted inflammatory responses. Since Tregs are able to reduce inflammation, it may be a promising therapy for T2D. Here, we will deepen our understanding of Tregs in the context of T2D and explore the potential use of Tregs as an innovative therapy for T2D. I hypothesize that insulin can possibly interfere with the functions of Tregs. I will investigate whether the ability of Tregs to suppress inflammation becomes defective due to high insulin exposure. I will next study the role of Tregs in T2D, and determine whether the increased inflammation in T2D is due to high insulin exposure interfering with the normal function of Tregs. I will also explore the potential use of Tregs as a therapy to treat T2D in mouse models. Specifically, I will investigate whether therapy with Tregs can reduce inflammation and reduce insulin resistance in these models. Overall, the data obtained here will potentially lead to improvements in existing diabetes treatments, and the development of an innovative Treg based therapy to treat diabetes.
Competitiondate
201102
Approvedterm2
1 yr 0 mth
Pinamesdelim
Han, Jonathan M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~